Ortin Global Limited (ORTINGLOBE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ortin Global Limited (ORTINGLOBE) has a cash flow conversion efficiency ratio of -0.597x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-7.75 Million ≈ $-83.86K USD) by net assets (Rs13.00 Million ≈ $140.55K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ORTINGLOBE net asset quality score to measure how much of total assets are equity-financed.
Ortin Global Limited - Cash Flow Conversion Efficiency Trend (2021–2026)
This chart illustrates how Ortin Global Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ortin Global Limited (ORTINGLOBE) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Ortin Global Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ortin Global Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
|
0.106x |
|
Smartfren Telecom Tbk
JK:FREN
|
-0.016x |
|
Elbit Med Tech
TA:EMTC
|
-0.005x |
|
Peel Hunt Ltd
LSE:PEEL
|
0.134x |
|
Fuse Cobalt Inc
V:FUSE
|
-0.057x |
|
Gaucho Group Holdings Inc
NASDAQ:VINO
|
-0.853x |
|
Europa Metals Ltd
JSE:EUZ
|
-0.110x |
|
Arcadia Biosciences Inc
NASDAQ:RKDA
|
-0.208x |
Annual Cash Flow Conversion Efficiency for Ortin Global Limited (2021–2026)
The table below shows the annual cash flow conversion efficiency of Ortin Global Limited from 2021 to 2026. For the full company profile with market capitalisation and key ratios, see Ortin Global Limited market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs12.37 Million ≈ $133.79K |
Rs-5.62 Million ≈ $-60.76K |
-0.454x | -118.87% |
| 2025-03-31 | Rs19.77 Million ≈ $213.86K |
Rs-4.10 Million ≈ $-44.37K |
-0.207x | +87.76% |
| 2024-03-31 | Rs28.24 Million ≈ $305.39K |
Rs-47.87 Million ≈ $-517.71K |
-1.695x | -7171.33% |
| 2023-03-31 | Rs108.65 Million ≈ $1.17 Million |
Rs-2.53 Million ≈ $-27.39K |
-0.023x | -111.89% |
| 2022-03-31 | Rs109.57 Million ≈ $1.18 Million |
Rs21.48 Million ≈ $232.29K |
0.196x | -87.66% |
| 2021-03-31 | Rs113.56 Million ≈ $1.23 Million |
Rs180.34 Million ≈ $1.95 Million |
1.588x | -- |
About Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more